News - XOMA Corp

Filter

Current filters:

XOMA Corp

Popular Filters

XOMA's partner Servier launches proof-of-concept clinical program for gevokizumab

25-06-2013

US drug developer XOMA Corp (Nasdaq: XOMA) says that its development partner, French independent drugmaker…

Anti-Arthritics/RheumaticsgevokizumabInflammatory diseasesPharmaceuticalResearchServierXOMA Corp

XOMA and Servier sign manufacturing deal with Boehringer for gevokizumab

06-08-2012

US therapeutic antibody discovery firm XOMA Corp (Nasdaq: XOMA) its partner France's Laboratoires Servier…

Boehringer IngelheimgevokizumabLicensingOphthalmicsPharmaceuticalProductionServierXOMA Corp

XOMA's allosteric insulin receptor-activating antibody first to improve glycemic control in vivo

12-03-2012

US therapeutic antibody discovery firm XOMA Corp (Nasdaq: XOMA) announced that results from a study of…

DiabetesPharmaceuticalResearchXmetAXOMA Corp

XOMA acquires US rights to perindopril franchise

18-01-2012

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has acquired US rights to the perindopril franchise…

AceonCardio-vascularMergers & AcquisitionsperindoprilPharmaceuticalServierXOMA Corp

Executive changes at Onyx Pharma and XOMA

02-09-2011

Onyx Pharmaceuticals (Nasdaq: ONXX) has appointed Helen Torley as executive vice president and chief…

ManagementOnyx PharmaceuticalsPharmaceuticalXOMA Corp

Back to top